Bioinformatics Analysis for Identification of Key Genes in Salivary Gland and the Potential of a Combination of Biomarkers for the Diagnosis of SS

References

• Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983–1989. doi:10.1136/annrheumdis-2014-205375
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Acar-Denizli N, Ng WF, et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren’s syndrome. Rheumatology. 2020;59:2350–2359. doi:10.1093/rheumatology/kez578
   PubMed Web of Science ®Google Scholar
• Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, et al. Long-term follow-up in primary Sjögren’s syndrome reveals differences in clinical presentation between female and male patients. Biol Sex Differ. 2017;8:25. doi:10.1186/s13293-017-0146-6
   PubMed Web of Science ®Google Scholar
• Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers JO, Jousse-Joulin S, Saraux A. B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39:161–167. doi:10.1016/j.jaut.2012.05.014
   PubMed Web of Science ®Google Scholar
• Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet. 2013;45:1284–1292. doi:10.1038/ng.2792
   PubMed Web of Science ®Google Scholar
• Campos J, Hillen MR, Barone F. Salivary gland pathology in Sjögren’s syndrome. Rheum Dis Clin North Am. 2016;42:473–483. doi:10.1016/j.rdc.2016.03.006
   PubMed Web of Science ®Google Scholar
• Baldini C, Ferro F, Elefante E, Bombardieri S. Biomarkers for Sjögren’s syndrome. Biomark Med. 2018;12:275–286. doi:10.2217/bmm-2017-0297
   PubMed Web of Science ®Google Scholar
• Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren’s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren’s syndrome. Ann Rheum Dis. 1994;53:637–647. doi:10.1136/ard.53.10.637
   PubMed Web of Science ®Google Scholar
• Fisher BA, Jonsson R, Daniels T, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis. 2017;76:1161–1168. doi:10.1136/annrheumdis-2016-210448
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Theander E, Baldini C, et al. Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol. 2016;12:137–156. doi:10.1586/1744666X.2016.1109449
   PubMed Web of Science ®Google Scholar
• Aringhieri G, Izzetti R, Vitali S, et al. Ultra-high frequency ultrasound (UHFUS) applications in Sjogren syndrome: narrative review and current concepts. Gland Surg. 2020;9:2248–2259. doi:10.21037/gs-20-529
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16. doi:10.1136/annrheumdis-2016-210571
   PubMed Web of Science ®Google Scholar
• Fox RI. Sjögren’s syndrome. Lancet. 2005;366:321–331. doi:10.1016/S0140-6736(05)66990-5
   PubMed Web of Science ®Google Scholar
• Wang B, Chen S, Zheng Q, et al. Early diagnosis and treatment for Sjögren’s syndrome: current challenges, redefined disease stages and future prospects. J Autoimmun. 2021;117:102590. doi:10.1016/j.jaut.2020.102590
   PubMed Web of Science ®Google Scholar
• Cui G, Sugai S, Ogawa Y, Takeshita S, Masaki Y. [Evaluation of the histologic criteria for the diagnosis of Sjögren’s syndrome]. Nihon Rinsho Men’eki Gakkai Kaishi = Japanese Journal of Clinical Immunology. 1999;22:72–79. Japanese. doi:10.2177/jsci.22.72
   PubMedGoogle Scholar
• Bautista-Vargas M, Vivas AJ, Tobón GJ. Minor salivary gland biopsy: its role in the classification and prognosis of Sjögren’s syndrome. Autoimmun Rev. 2020;19:102690. doi:10.1016/j.autrev.2020.102690
   PubMed Web of Science ®Google Scholar
• Kroese F, Haacke E, Bombardieri M. The role of salivary gland histopathology in primary Sjögren’s syndrome: promises and pitfalls. Clin Exp Rheumatol. 2018;36:222–233.
   PubMedGoogle Scholar
• Elder EG, Krishna BA, Williamson J, et al. Interferon-responsive genes are targeted during the establishment of human cytomegalovirus latency. mBio. 2019;10:e02574–19. doi:10.1128/mBio.02574-19
   PubMed Web of Science ®Google Scholar
• Xuan J, Ji Z, Wang B, et al. Serological evidence for the association between Epstein-Barr virus infection and Sjögren’s syndrome. Front Immunol. 2020;11:2826. doi:10.3389/fimmu.2020.590444
   Web of Science ®Google Scholar
• Marketos N, Cinoku I, Rapti A, Mavragani CP. Type I interferon signature in Sjögren’s syndrome: pathophysiological and clinical implications. Clin Exp Rheumatol. 2019;37(Suppl 118):185–191.
   PubMedGoogle Scholar
• Bodewes I, Björk A, Versnel M, Wahren-Herlenius M. Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome. Rheumatology. 2019;60:2561–2573.
   Web of Science ®Google Scholar
• Barrat F, Crow M, Ivashkiv L. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20:1574–1583. doi:10.1038/s41590-019-0466-2
   PubMed Web of Science ®Google Scholar
• Mavragani C, Sagalovskiy I, Guo Q, et al. Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease. Arthritis Rheum. 2016;68:2686–2696. doi:10.1002/art.39795
   PubMed Web of Science ®Google Scholar
• Rauch I, Müller M, Decker T. The regulation of inflammation by interferons and their STATs. Jak-Stat. 2013;2:e23820. doi:10.4161/jkst.23820
   PubMedGoogle Scholar
• Davies R, Hammenfors D, Bergum B, et al. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren’s syndrome patients associates with type I interferon signature. Eur J Immunol. 2018;48:1217–1227. doi:10.1002/eji.201747213
   PubMed Web of Science ®Google Scholar
• Lee J, Lee J, Kwok SK, et al. JAK-1 inhibition suppresses interferon-induced BAFF production in human salivary gland: potential therapeutic strategy for primary Sjögren’s syndrome. Arthritis Rheumatol. 2018;70:2057–2066. doi:10.1002/art.40589
   PubMed Web of Science ®Google Scholar
• Briggs RC, Briggs JA, Ozer J, et al. The human myeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cells. Blood. 1994;83:2153–2162. doi:10.1182/blood.V83.8.2153.2153
   PubMed Web of Science ®Google Scholar
• Mondini M, Costa S, Sponza S, Gugliesi F, Gariglio M, Landolfo S. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity. 2010;43:226–231. doi:10.3109/08916930903510922
   PubMed Web of Science ®Google Scholar
• Hu S, Gao K, Pollard R, et al. Preclinical validation of salivary biomarkers for primary Sjögren’s syndrome. Arthritis Care Res. 2010;62:1633–1638. doi:10.1002/acr.20289
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765. doi:10.1146/annurev.immunol.19.1.683
   PubMed Web of Science ®Google Scholar
• Colafrancesco S, Ciccacci C, Priori R, et al. STAT4, TRAF3IP2, IL10, and HCP5 polymorphisms in Sjögren’s syndrome: association with disease susceptibility and clinical aspects. J Immunol Res. 2019;2019:7682827. doi:10.1155/2019/7682827
   PubMed Web of Science ®Google Scholar
• Cabral-Marques O, Schimke LF, de Oliveira EB, et al. Flow cytometry contributions for the diagnosis and immunopathological characterization of primary immunodeficiency diseases with immune dysregulation. Front Immunol. 2019;10:2742. doi:10.3389/fimmu.2019.02742
   PubMed Web of Science ®Google Scholar
• Lin X, Wang X, Xiao F, et al. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren’s syndrome. Cell Mol Immunol. 2019;16:921–931. doi:10.1038/s41423-019-0227-z
   PubMed Web of Science ®Google Scholar
• Dyer DP, Medina-Ruiz L, Bartolini R, et al. Chemokine receptor redundancy and specificity are context dependent. Immunity. 2019;50(2):378–389.e5. doi:10.1016/j.immuni.2019.01.009
   PubMed Web of Science ®Google Scholar
• Chou PH, Chee A, Shi P, et al. Small molecule antagonist of C-C chemokine receptor 1 (CCR1) reduces disc inflammation in the rabbit model. Spine J. 2020;20:2025–2036. doi:10.1016/j.spinee.2020.07.001
   PubMed Web of Science ®Google Scholar